EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity

Author：                  

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.30, Iss.1, 2012-01, pp. : 69-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inability of NCoR/SMRT to repress androgen receptor transcriptional activity in prostate cancer cell lines

By Laschak Martin   Bechtel Marina   Spindler Klaus-Dieter   Hessenauer Andrea  

International Journal of Molecular Medicine, Vol. 28, Iss. 4, 2011-10 ,pp. : 645-651

Spandidos Publications

Access to resources Recommend Favorite

Androgen receptor‐interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen‐deficient conditions

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 11, 2015-06 ,pp. : 2535-2545

John Wiley & Sons Inc

Access to resources Recommend Favorite

The transcriptional programme of the androgen receptor (AR) in prostate cancer

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 358-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells

By  

THE PROSTATE, Vol. 73, Iss. 12, 2013-09 ,pp. : 1306-1315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Valproic acid-induced histone acetylation suppresses CYP19 gene expression and inhibits the growth and survival of endometrial stromal cells

By        

International Journal of Molecular Medicine, Vol. 36, Iss. 3, 2015-01 ,pp. : 725-732

Spandidos Publications

Access to resources Recommend Favorite